Search

Search Constraints

You searched for: Author/Creator Sarkaria, Jann N

Search Results

1. Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery. Issue 10 (7th June 2020)

2. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. Issue 5 (May 2018)

4. Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. (16th May 2018)

5. Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts. (24th August 2022)

6. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Issue 12 (31st July 2019)

8. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Issue 2 (7th September 2017)

10. Molecular profiling of long-term IDH-wildtype glioblastoma survivors. Issue 11 (26th July 2019)